Published in Br J Cancer on October 09, 2007
CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer. Oncotarget (2015) 0.87
Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in canine simple mammary gland adenocarcinomas. Can Vet J (2010) 0.87
Bridging population and tissue scale tumor dynamics: a new paradigm for understanding differences in tumor growth and metastatic disease. Cancer Res (2014) 0.85
Blood vessel invasion and other variables as predictors of long-term survival in Japanese and British patients with primary invasive breast cancer. Int J Clin Exp Pathol (2014) 0.77
Contrast enhanced computed tomography is indicative for angiogenesis pattern and display prognostic significance in breast cancer. BMC Cancer (2014) 0.75
Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep (1966) 48.83
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology (1991) 30.87
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med (1991) 19.46
Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol (1990) 4.60
Sudden fall in breast cancer death rates in England and Wales. Lancet (1995) 4.50
Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst (1994) 4.28
Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet (1992) 4.10
Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst (1995) 3.96
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol (1994) 3.48
Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol (1995) 2.52
Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol (1992) 2.19
Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J Nutr (2002) 1.48
Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum Pathol (1995) 1.39
Survival differences in breast cancer among racial/ethnic groups: a population-based study. Cancer Detect Prev (1999) 1.37
Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer (1993) 1.36
A COMPARISON OF SURVIVAL RATES BETWEEN AMERICAN AND JAPANESE PATIENTS WITH BREAST CANCER. Surg Gynecol Obstet (1963) 1.29
Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum Pathol (1995) 1.28
Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients. Histopathology (2004) 1.21
Racial differences in survival of female breast cancer in the Detroit metropolitan area. Cancer (1996) 1.09
The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer. Br J Cancer (2003) 1.09
Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int J Cancer (2006) 1.07
Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials. J Clin Oncol (2005) 1.06
Clinical significance of determination of surrogate markers of angiogenesis in breast cancer. Crit Rev Oncol Hematol (2001) 1.02
A case-control study of diet and breast cancer in Argentina. Int J Cancer (1989) 0.98
Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen. Br J Cancer (1995) 0.98
The methodology of quantitation of microvessel density and prognostic value of neovascularization associated with long-term survival in Japanese patients with breast cancer. Breast Cancer Res Treat (1999) 0.96
Ethnic differences in breast cancer in Hawai'i: age, stage, hormone receptor status, and survival. Pac Health Dialog (2004) 0.95
Some international differences in treatment and survival in breast cancer. Int J Cancer (1976) 0.93
Breast cancer in English and Japanese women: prognostic significance of sinus histiocytosis and germinal center hyperplasia in axillary lymph nodes. Breast Cancer Res Treat (1991) 0.92
Meta-analysis of five studies on tegafur plus uracil (UFT) as post-operative adjuvant chemotherapy for breast cancer. Oncology (2003) 0.91
Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer. Breast Cancer Res Treat (2001) 0.91
Impact of menstrual and reproductive factors on breast cancer risk in Japan: results of the JACC study. Cancer Sci (2005) 0.91
Tumor microvessel density and prognosis in node-negative breast cancer. Int J Cancer (2000) 0.88
Prognostic value of microvessel density in invasive ductal carcinoma of the breast. Breast Cancer (2003) 0.85
Cancer incidence and incidence rates in Japan in 1998: estimates based on data from 12 population-based cancer registries. Jpn J Clin Oncol (2003) 0.83
Epidemiology of Breast Cancer in Japan. Breast Cancer (1995) 0.82
Breast cancer in Japan and United States: epidemiology, hormone receptors, pathology, and survival. Arch Surg (1980) 0.82
Expression of c-erbB2 and p53 protein is similar in breast cancer from British and Japanese women. Int J Cancer (1999) 0.80
What caused the decline in breast cancer mortality in the United Kingdom? Breast Cancer (2004) 0.79
A comparison of epidemiological characteristics in breast cancer patients and normal women in Great Britain and Japan: results of a prospective study. Breast Cancer Res Treat (1991) 0.78
Comparison of breast cancer mortality in five countries: France, Italy, Japan, the UK and the USA from the WHO mortality database (1960-2000). Jpn J Clin Oncol (2005) 0.77
Breast cancer survival among Orientals and whites living in the United States. J Surg Oncol (1988) 0.76
Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol (1996) 72.84
A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (1988) 27.60
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood (1994) 21.00
A highly sensitive method to assay FK-506 levels in plasma. Transplant Proc (1987) 8.45
Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med (1992) 8.27
Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med (1991) 7.52
Laparoscopic cholecystectomy using fine-caliber instruments. Surg Endosc (1998) 6.36
Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol (1991) 6.30
Green revolution: a mutant gibberellin-synthesis gene in rice. Nature (2002) 5.84
Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res (2000) 5.74
Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci U S A (1997) 5.42
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res (1996) 5.38
An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol (1994) 5.34
The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol (2000) 5.21
Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science (1997) 5.13
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain (2009) 5.03
Complete genome structure of the nitrogen-fixing symbiotic bacterium Mesorhizobium loti. DNA Res (2000) 4.94
Dynamics of a small globular protein in terms of low-frequency vibrational modes. Proc Natl Acad Sci U S A (1983) 4.84
Identification of CRE1 as a cytokinin receptor from Arabidopsis. Nature (2001) 4.77
Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc Natl Acad Sci U S A (1987) 4.72
Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science (1994) 4.50
Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet (1990) 4.49
Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell (1993) 4.46
Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol (1990) 4.42
Standard steroid treatment for autoimmune pancreatitis. Gut (2009) 4.33
Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet (1987) 4.28
Complete genomic sequence of the filamentous nitrogen-fixing cyanobacterium Anabaena sp. strain PCC 7120. DNA Res (2001) 4.27
A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol Endocrinol (2000) 4.25
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology (2002) 4.22
Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet (1992) 4.10
bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med (1993) 4.05
High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol Sci (2001) 4.02
Regulation of drought tolerance by gene manipulation of 9-cis-epoxycarotenoid dioxygenase, a key enzyme in abscisic acid biosynthesis in Arabidopsis. Plant J (2001) 3.92
Equilibrium properties of a voltage-dependent junctional conductance. J Gen Physiol (1981) 3.91
Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood (1998) 3.67
The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis. Nature (1999) 3.65
Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. N Engl J Med (1983) 3.63
Ki67 protein: the immaculate deception? Histopathology (2002) 3.61
Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell (1994) 3.56
The Bloom's syndrome gene product interacts with topoisomerase III. J Biol Chem (2000) 3.52
Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer. Hepatology (2000) 3.42
Transferrin receptor on endothelium of brain capillaries. Nature (1984) 3.37
Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res (1989) 3.35
Bone density in women receiving depot medroxyprogesterone acetate for contraception. BMJ (1991) 3.34
Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn (1999) 3.33
Kinetic properties of a voltage-dependent junctional conductance. J Gen Physiol (1981) 3.33
HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res (2001) 3.27
Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol (1983) 3.23
Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut (2007) 3.11
Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer (2001) 3.10
JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol (1990) 3.10
Monoclonal antibody Ki-67: its use in histopathology. Histopathology (1990) 3.07
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer (1996) 3.07
Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci U S A (1995) 3.06
Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms. J Biol Chem (1991) 3.01
The complete sequence of the rice (Oryza sativa L.) mitochondrial genome: frequent DNA sequence acquisition and loss during the evolution of flowering plants. Mol Genet Genomics (2002) 2.93
Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int (2001) 2.90
Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology (1992) 2.83
Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci U S A (1991) 2.82
KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol (1989) 2.82
Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer (2002) 2.82
Successful treatment of Behçet disease with pentoxifylline. Ann Intern Med (1996) 2.81
Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet (1985) 2.76
Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med (1992) 2.71
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol (2001) 2.71
Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol (1982) 2.69
Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology (1998) 2.67
Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res (2001) 2.66
Gap junctional conductance is a simple and sensitive function of intracellular pH. Science (1981) 2.64
Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc (1981) 2.62
Molecular clock of silent substitution: at least six-fold preponderance of silent changes in mitochondrial genes over those in nuclear genes. J Mol Evol (1982) 2.58
eIF4E expression in tumors: its possible role in progression of malignancies. Int J Biochem Cell Biol (1999) 2.57
Complete nucleotide sequence of hepatitis B virus DNA of subtype adr and its conserved gene organization. Gene (1984) 2.56
Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol (1995) 2.52
Rice dwarf mutant d1, which is defective in the alpha subunit of the heterotrimeric G protein, affects gibberellin signal transduction. Proc Natl Acad Sci U S A (2000) 2.51
Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer (1999) 2.47
High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan. Gut (1999) 2.46
Evidence, hierarchies, and typologies: horses for courses. J Epidemiol Community Health (2003) 2.45
Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. Lancet (1985) 2.44